ImmuCell Corp. (ICCC)
9.84
-0.06
(-0.61%)
USD |
NASDAQ |
Sep 08, 16:00
9.97
+0.13
(+1.32%)
After-Hours: 20:00
ImmuCell Price : 9.84 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 9.82 | 10.02 | 9.80 | 9.84 | 15550.00 |
| Sep 04, 2026 | 9.97 | 9.97 | 9.80 | 9.90 | 11696.00 |
| Sep 03, 2026 | 9.90 | 10.04 | 9.90 | 10.00 | 14265.00 |
| Sep 02, 2026 | 9.825 | 10.09 | 9.825 | 10.00 | 16278.00 |
| Sep 01, 2026 | 9.85 | 10.02 | 9.835 | 9.92 | 6992.00 |
| Aug 31, 2026 | 9.86 | 10.00 | 9.77 | 9.79 | 20133.00 |
| Aug 28, 2026 | 10.30 | 10.30 | 9.89 | 9.94 | 5608.00 |
| Aug 27, 2026 | 10.00 | 10.16 | 10.00 | 10.02 | 3181.00 |
| Aug 26, 2026 | 9.85 | 10.34 | 9.85 | 10.02 | 7430.00 |
| Aug 25, 2026 | 9.87 | 10.12 | 9.73 | 9.84 | 27469.00 |
| Aug 24, 2026 | 10.06 | 10.06 | 9.76 | 9.84 | 54670.00 |
| Aug 21, 2026 | 10.09 | 10.49 | 10.05 | 10.06 | 11132.00 |
| Aug 20, 2026 | 10.14 | 10.26 | 9.775 | 10.09 | 83717.00 |
| Aug 19, 2026 | 9.76 | 10.38 | 9.61 | 10.13 | 48764.00 |
| Aug 18, 2026 | 9.73 | 9.86 | 9.629 | 9.76 | 15145.00 |
| Aug 17, 2026 | 10.00 | 10.00 | 9.55 | 9.70 | 100989.0 |
| Aug 14, 2026 | 10.72 | 10.72 | 9.75 | 10.05 | 92025.00 |
| Aug 13, 2026 | 10.96 | 11.14 | 10.86 | 10.90 | 44695.00 |
| Aug 12, 2026 | 10.80 | 11.06 | 10.47 | 10.98 | 26828.00 |
| Aug 11, 2026 | 11.06 | 11.09 | 10.62 | 10.95 | 14490.00 |
| Aug 10, 2026 | 11.10 | 11.10 | 10.86 | 10.97 | 12148.00 |
| Aug 07, 2026 | 10.95 | 11.03 | 10.76 | 11.00 | 9705.00 |
| Aug 06, 2026 | 10.82 | 11.31 | 10.62 | 11.02 | 41568.00 |
| Aug 05, 2026 | 11.16 | 11.38 | 10.50 | 10.75 | 15132.00 |
| Aug 04, 2026 | 10.99 | 11.25 | 10.91 | 11.07 | 27583.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.58 |
| Alnylam Pharmaceuticals, Inc. | 260.10 |
| Anika Therapeutics, Inc. | 21.04 |
| Savara, Inc. | 5.53 |
| Vericel Corp. | 39.08 |
Price Related Metrics
| PE Ratio | 117.42 |
| PS Ratio | 2.913 |
| Price to Book Value | 2.848 |
| Price to Free Cash Flow | 21.20 |
| Earnings Yield | 0.85% |
| Market Cap | 89.37M |
| Operating PE Ratio | 47.88 |
| Normalized PE Ratio | 71.36 |